Edition:
United States

ImmuCell Corp (ICCC.OQ)

ICCC.OQ on NASDAQ Stock Exchange Capital Market

7.33USD
23 Feb 2018
Change (% chg)

$0.11 (+1.52%)
Prev Close
$7.22
Open
$7.20
Day's High
$7.33
Day's Low
$7.20
Volume
161
Avg. Vol
2,622
52-wk High
$9.25
52-wk Low
$5.00

Latest Key Developments (Source: Significant Developments)

ImmuCell Announces Q4 Loss Per Share $0.04
Thursday, 8 Feb 2018 04:05pm EST 

Feb 8 (Reuters) - ImmuCell Corp ::IMMUCELL ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2017.Q4 LOSS PER SHARE $0.04.PRELIMINARY QTRLY TOTAL PRODUCT SALES $3.1 MILLION VERSUS $2.2 MILLION.  Full Article

ImmuCell Corp Announces Pricing Of $3 Mln Public Offering Of Common Shares
Tuesday, 19 Dec 2017 06:30am EST 

Dec 19 (Reuters) - Immucell Corp ::IMMUCELL CORPORATION ANNOUNCES PRICING OF $3 MILLION PUBLIC OFFERING OF COMMON SHARES.IMMUCELL CORP - UNDERWRITTEN PUBLIC OFFERING OF 417,807 SHARES OF STOCK AT A PRICE TO PUBLIC OF $7.30 PER SHARE.IMMUCELL CORP - ALSO ANNOUNCED ESTIMATED REVENUES FOR TWELVE-MONTH PERIOD ENDED NOVEMBER 30, 2017 EXPECTED TO INCREASE BY 9% TO $10.2 MILLION.  Full Article

Immucell Q3 loss per share $0.07
Monday, 13 Nov 2017 04:05pm EST 

Nov 13 (Reuters) - Immucell Corp ::Immucell announces financial results for third quarter of 2017.Q3 loss per share $0.07.Immucell - ‍during 3-month period ended Sept 30, 2017, total product sales were just over $2 million versus just under $2 million during same quarter of 2016​.  Full Article

ImmuCell announces expansion of sales and marketing team
Wednesday, 13 Sep 2017 06:30am EDT 

Sept 13 (Reuters) - ImmuCell Corp :ImmuCell Corp - ‍during Q4 of 2017, company expects to achieve regulatory approval of First Defense Tri-Shield​.ImmuCell Corp - working to also achieve regulatory approval of First Defense Dual-Force, during Q4 2017.  Full Article

ImmuCell Q2 loss per share $0.05
Monday, 14 Aug 2017 04:05pm EDT 

Aug 14 (Reuters) - Immucell Corp :ImmuCell announces financial results for second quarter of 2017.Q2 loss per share $0.05.Qtrly ‍product sales $1.8 million versus $2.4 million ​.  Full Article

Immucell enters into amendment to agreement with Plas-Pak Industries
Tuesday, 25 Jul 2017 11:04am EDT 

July 25 (Reuters) - Immucell Corp ::On July 24, co entered into amendment to agreement with Plas-Pak Industries of Norwich, Connecticut, originally dated as of January 4, 2010.Says current amendment extends expiration date of agreement by three years to January 1, 2024 - SEC filing.  Full Article

Immucell Corp sees FDA approval for Mast Out in 2019
Tuesday, 11 Oct 2016 11:45am EDT 

Immucell Corp :Immucell Corp - U.S. FDA approval for co's product Mast Out anticipated in 2019, allowing for two, six-month reviews of cmc technical section by FDA.  Full Article

Immucell posts Q2 earnings per share $0.00
Thursday, 11 Aug 2016 04:05pm EDT 

Immucell Corp : Immucell announces second quarter 2016 financial results . Q2 sales rose 21 percent to $2.4 million .Q2 earnings per share $0.00.  Full Article

Immucell Q1 earnings per share $0.11
Wednesday, 11 May 2016 04:16pm EDT 

Immucell Corp : Immucell announces first quarter 2016 financial results . Q1 earnings per share $0.11 .Q1 sales fell 3.7 percent to $3.0 million.  Full Article

BRIEF-ImmuCell Announces Q4 Loss Per Share $0.04

* IMMUCELL ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2017

No consensus analysis data available.